Abstract Treatment outcomes for major depressive disorder (MDD) need to be improved.
Presently, no clinically relevant tools have been established for stratifying subgroups or …

Depression in bipolar disorder (BD) patients presents major clinical challenges. As the
predominant psychopathology even in treated BD, depression is associated not only with …

Multimodal signals are powerful for emotion recognition since they can represent emotions
comprehensively. In this article, we compare the recognition performance and robustness of …

Clinically approved neural stimulators are limited by battery requirements, as well as by their
large size compared with the stimulation targets. Here, we describe a wireless, leadless and …

Deep brain stimulation (DBS) has emerged as a promising treatment for select patients with
refractory major depressive disorder (MDD). The clinical effectiveness of DBS for MDD has …

Subthalamic deep brain stimulation (DBS) for Parkinson disease (PD) currently requires
laborious open-loop programming, which can mitigate the benefits of this treatment …

Deficits in cognitive control—that is, in the ability to withhold a default pre-potent response in
favour of a more adaptive choice—are common in depression, anxiety, addiction and other …

Interest in neurostimulation interventions has significantly grown in recent decades, yet a
scientometric analysis objectively map** scientific knowledge and recent trends remains …

Deep brain stimulation (DBS) is a promising intervention for treatment-resistant psychiatric
disorders, particularly major depressive disorder (MDD) and obsessive-compulsive disorder …

Deep brain stimulation (DBS) is a circuit-oriented treatment for mental disorders.
Unfortunately, even well-conducted psychiatric DBS clinical trials have yielded inconsistent …